16553355

Source:http://linkedlifedata.com/resource/pubmed/id/16553355

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012963, umls-concept:C0246904, umls-concept:C1707455
pubmed:issue	2
pubmed:dateCreated	2006-3-23
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16553355-16200918
pubmed:language	spa
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0134516
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cardiotonic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Dobutamine, http://linkedlifedata.com/resource/pubmed/chemical/Hydrazones, http://linkedlifedata.com/resource/pubmed/chemical/Pyridazines, http://linkedlifedata.com/resource/pubmed/chemical/simendan
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0034-9356
pubmed:author	pubmed-author:Martos Fernández de CórdobaFF
pubmed:issnType	Print
pubmed:volume	53
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	132-3; author reply 133
pubmed:dateRevised	2009-11-11
pubmed:meshHeading	pubmed-meshheading:16553355-Cardiotonic Agents, pubmed-meshheading:16553355-Dobutamine, pubmed-meshheading:16553355-Humans, pubmed-meshheading:16553355-Hydrazones, pubmed-meshheading:16553355-Pyridazines
pubmed:year	2006
pubmed:articleTitle	[On levosimendan in comparison with dobutamine].
pubmed:publicationType	Letter, Comparative Study, Comment